,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destiny-breast04', 'daiichisankyous', 'astrazenecaus', 'astrazeneca']
new data from the destiny-breast04 trial for certain patients with her2-low metastatic #breastcancer were presented at #asco22 with our collaborators and published in . read more: 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.